Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
adalimumab, adult, Amgen, analyzing, baricitinib, bladder, Buffalo, comparison, concentrated, concentration, Corrupt, Daly, diabetic, GlaxoSmithKline, ipilimumab, jakavi, jeopardize, jurisdiction, mandatory, nephropathy, North, pharmacist, proliferative, prominence, ratio, reinstated, Relief, renal, retroactive, retroactively, structural, SUNY, synthesized, urinary, usage
Removed:
absorbed, activate, actively, affiliated, agent, backed, behavior, bifurcated, bifurcation, binomial, bond, brand, Bristol, classification, compliant, concurrent, consultant, coupon, derivative, differentiated, diverse, durable, eliminating, Elimination, embedded, endocrinology, executed, execution, feature, generation, geographic, halt, hematocrit, HIV, indexed, initiating, instrument, john, lattice, Marine, Michigan, Midland, mix, mortgage, muscle, negotiated, niblack, ophthalmology, placement, pledged, political, privately, pro, profile, progressing, protected, qualitative, quantitative, rata, reclassified, recused, remeasured, revalued, science, Secretary, separately, stand, stringent, strive, strong, topical, transition, understand, unissued, unsuitable, variable, voting
Filing tables
Filing exhibits
Related press release
INCY similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
STATEMENT PURSUANT TO
18 U.S.C. SECTION 1350
With reference to the Annual Report of Incyte Corporation (the "Company") on Form 10-K for the year ended December 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, David C. Hastings, Chief Financial Officer of the Company, certify, for the purposes of 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
- (1)
- the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
- (2)
- the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ DAVID C. HASTINGS David C. Hastings Chief Financial Officer February 21, 2013 |